查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786759

体外转录模板的全球市场

In-Vitro Transcription Templates
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 242 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球体外转录模板市场规模将达 10 亿美元

全球体外转录模板市场规模预计在2024年达到3.585亿美元，预计在分析期内（2024-2030年）将以18.9%的复合年增长率增长，到2030年将达到10亿美元。 DNA模板是本报告分析的细分市场之一，预计其复合年增长率将达到17.3%，到分析期结束时达到3.953亿美元。 RNA模板细分市场在分析期间内的复合年增长率预计为17.5%。

美国市场规模估计为 9,420 万美元，中国市场预计复合年增长率为 17.9%

美国体外转录模板市场规模预计在2024年达到9,420万美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.562亿美元，在2024-2030年的分析期间内，复合年增长率为17.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为17.1%和16.5%。在欧洲，预计德国市场的复合年增长率约为14.0%。

体外转录模板－主要趋势与市场驱动因素摘要

体外转录 (IVT) 模板已成为分子生物学、生物技术和生物製药研究中必不可少的工具，为各种应用的 RNA 合成提供了基础。这些模板通常源自 DNA质体或线性 DNA 片段，可用于生产用于 mRNA 疗法、疫苗开发、基因治疗和基于 CRISPR 的基因组编辑的合成 RNA。对高纯度、可扩展 RNA 合成的需求日益增长，尤其是在基于 mRNA 的疫苗和治疗方法的开发方面，这极大地推动了 IVT 模板技术的进步。随着 RNA 药物的不断扩展，对优化且高效的 IVT 模板的需求正在显着改变合成生物学和治疗方法开发的模式。

科技创新如何增强体外转录模板？

IVT模板设计和合成技术的进步显着提高了体外转录RNA的效率、稳定性和产量。其中最显着的创新之一是开发了优化的启动子序列以提高转录效率。 T7、SP6和T3 RNA聚合酵素启动子已被广泛改造，以最大限度地提高RNA产量，同时最大限度地减少不必要的副产物，例如截短的RNA和异常的RNA。此外，改进的poly(A)加尾策略和5'-加帽技术已纳入IVT模板设计中，以提高RNA的稳定性和翻译效率，从而用于治疗应用。

另一项关键创新是转向使用基于PCR方法产生的线性DNA模板。与质体DNA模板不同，线性DNA片段无需纯化超螺旋质体，从而降低了製程复杂性并提高了批次间一致性。高保真DNA聚合酵素和模板工程策略的使用进一步提高了IVT模板的品质和扩充性，使其更适合大规模RNA生产。此外，CleanCap™和Cap1构建等酶促加帽方法的整合显着提高了合成RNA的功能稳定性，这对于基于mRNA的疫苗和疗法至关重要。

哪些市场趋势推动了 IVT 模板的演变？

基于 mRNA 的 COVID-19 疫苗已证明 IVT 产生的 RNA 在快速药物开发方面具有巨大潜力。这项成功刺激了对 RNA 药物研发管线的大量投资，製药和生物技术公司正在扩展 IVT 模板能力，以用于癌症免疫疗法、蛋白质替代疗法和个人化疫苗。 mRNA 技术在感染疾病疫苗、自体免疫疾病和罕见遗传疾病领域的应用日益广泛，这推动了 IVT 模板优化领域的创新。

另一个重要趋势是人们对基于 CRISPR 的基因编辑技术的兴趣日益浓厚，其中 IVT 模板在嚮导 RNA (gRNA) 的合成中起着关键作用。随着 CRISPR-Cas9 及相关技术的不断发展，对高纯度、精准设计的 RNA 转录本的需求日益增长。这推动了模板纯化策略、无错误合成方法和可扩展生产过程的进步，以确保基因组编辑应用的高保真度。

此外，合成生物学和基于RNA的诊断技术的扩展正在塑造IVT模板市场。研发人员正在利用IVT模板製造RNA感测器、RNA适体和生物感测技术，进而推动下一代分子诊断技术的开发。这一趋势对于感染疾病诊断中的就地检验（POCT）和快速核酸检测尤其重要，因为IVT产生的RNA探针可以提高检测的敏感度和特异性。

推动 IVT 模板市场成长的因素有哪些？

体外转录模板市场的成长受到多种因素的推动，包括对基于RNA的疗法的需求不断增长、模板合成技术的进步以及在生物技术和分子医学领域的应用不断拓展。 mRNA药物开发平臺的快速扩张是其关键的成长要素。 mRNA疫苗的成功促使製药公司和研究机构的投资激增，他们致力于开发针对多种疾病的新型RNA治疗方法，推动了对优化IVT模板的需求。

在基于 CRISPR 的基因编辑和细胞疗法应用中，IVT 模板的日益普及也是推动市场成长的主要因素。基因编辑技术的进步正在加速对高品质 IVT 生成的嚮导 RNA 和模板驱动的 RNA 分子的需求，从而支持基因治疗、再生医学和精准医疗领域的突破。此外，对个人化医疗和 RNA 诊断的日益关注也推动了对可扩展和可自订 IVT 模板解决方案的需求。

向酶合成和高纯度RNA製造的转变也是製药和生物技术公司寻求简化RNA製造流程并维持严格品管标准的关键驱动力。随着监管部门对RNA疗法的关注日益增加，各公司正在投资先进的模板合成技术，例如无错误转录系统和无污染酶促方法，以确保符合良好生产规范(GMP)。此外，学术研究机构、生物技术公司以及受託製造厂商(CDMO)之间的合作正在加速IVT模板的创新，从而实现RNA疗法的大规模生产和商业化。

随着基于 RNA 的药物继续彻底改变医疗保健，对高效、可扩展且精确设计的体外转录模板的需求预计将扩大并塑造合成生物学、基因医学和生物製药开发的未来。

部分

产品类型（DNA模板、RNA模板、模板及转录套件、其他产品类型）；疾病（文明病、遗传疾病、其他）；治疗（疫苗、治疗学）；研究阶段（探索性、临床）；最终用户（製药和生物技术公司、学术和研究机构、受託研究机构）

受访公司范例

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen NV
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP31688

Global In-Vitro Transcription Templates Market to Reach US$1.0 Billion by 2030

The global market for In-Vitro Transcription Templates estimated at US$358.5 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 18.9% over the analysis period 2024-2030. DNA templates, one of the segments analyzed in the report, is expected to record a 17.3% CAGR and reach US$395.3 Million by the end of the analysis period. Growth in the RNA templates segment is estimated at 17.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$94.2 Million While China is Forecast to Grow at 17.9% CAGR

The In-Vitro Transcription Templates market in the U.S. is estimated at US$94.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$156.2 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.1% and 16.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.0% CAGR.

In-Vitro Transcription Templates - Key Trends & Market Drivers Summarized

In-vitro transcription (IVT) templates have become an essential tool in molecular biology, biotechnology, and biopharmaceutical research, serving as the foundation for RNA synthesis in various applications. These templates, typically derived from DNA plasmids or linear DNA fragments, enable the production of synthetic RNA for mRNA therapeutics, vaccine development, gene therapy, and CRISPR-based genome editing. The increasing demand for high-purity and scalable RNA synthesis, particularly in the development of mRNA-based vaccines and therapies, has significantly boosted advancements in IVT template technology. As RNA-based medicine continues to expand, the need for optimized and efficient IVT templates is reshaping the landscape of synthetic biology and therapeutic development.

How Are Technological Innovations Enhancing In-Vitro Transcription Templates?

Technological advancements in IVT template design and synthesis have significantly improved the efficiency, stability, and yield of in-vitro transcribed RNA. One of the most notable innovations is the development of optimized promoter sequences that enhance transcription efficiency. The T7, SP6, and T3 RNA polymerase promoters have been extensively engineered to maximize RNA yield while minimizing unwanted byproducts such as truncated or aberrant RNA species. Additionally, modifications in poly(A) tailing strategies and 5' capping technologies have been integrated into IVT template designs to improve RNA stability and translational efficiency for therapeutic applications.

Another key innovation is the shift toward linear DNA templates generated through PCR-based methods. Unlike plasmid DNA templates, linear DNA fragments eliminate the need for supercoiled plasmid purification, reducing process complexity and improving batch-to-batch consistency. The use of high-fidelity DNA polymerases and template engineering strategies has further enhanced the quality and scalability of IVT templates, making them more suitable for large-scale RNA production. Furthermore, the integration of enzymatic capping methods such as CleanCap™ and Cap1 structures has significantly improved the functional stability of synthetic RNA, which is crucial for mRNA-based vaccines and therapeutics.

What Market Trends Are Driving the Evolution of IVT Templates?

The rise of mRNA therapeutics and vaccines has been the most transformative trend in the IVT template market, with mRNA-based COVID-19 vaccines demonstrating the vast potential of IVT-generated RNA for rapid drug development. This success has spurred significant investment in RNA-based drug pipelines, with pharmaceutical companies and biotech firms expanding their IVT template capabilities for cancer immunotherapies, protein replacement therapies, and personalized vaccines. The increasing adoption of mRNA-based technologies in infectious disease vaccines, autoimmune disorders, and rare genetic conditions is driving innovation in IVT template optimization.

Another critical trend is the growing interest in CRISPR-based gene editing, where IVT templates serve as a key component in the synthesis of guide RNAs (gRNAs). As CRISPR-Cas9 and related technologies continue to evolve, the demand for highly pure and precisely engineered RNA transcripts is increasing. This has led to advancements in template purification strategies, error-free synthesis methods, and scalable production processes to ensure high fidelity in genome editing applications.

Additionally, the expansion of synthetic biology and RNA-based diagnostics is shaping the IVT template market. Researchers are leveraging IVT templates for the production of RNA sensors, RNA aptamers, and biosensing technologies, enabling the development of next-generation molecular diagnostics. This trend is particularly relevant for point-of-care testing (POCT) and rapid nucleic acid detection in infectious disease diagnostics, where IVT-generated RNA probes enhance assay sensitivity and specificity.

What Is Driving the Growth of the IVT Template Market?

The growth in the in-vitro transcription template market is driven by several factors, including the increasing demand for RNA-based therapies, advancements in template synthesis technologies, and expanding applications in biotechnology and molecular medicine. A major growth driver is the rapid expansion of mRNA-based drug development pipelines. The success of mRNA vaccines has prompted a surge in investment from pharmaceutical companies and research institutions seeking to develop novel RNA-based treatments for a wide range of diseases, thereby increasing the need for optimized IVT templates.

Another significant factor fueling market growth is the rising adoption of IVT templates in CRISPR-based gene editing and cell therapy applications. As gene-editing technologies advance, the demand for high-quality IVT-generated guide RNAs and template-driven RNA molecules is accelerating, supporting breakthroughs in gene therapy, regenerative medicine, and precision medicine. Additionally, the increasing focus on personalized medicine and RNA-based diagnostics is driving the need for scalable and customizable IVT template solutions.

The shift toward enzymatic synthesis and high-purity RNA production is also a crucial driver, as pharmaceutical and biotech companies seek to streamline RNA manufacturing processes while maintaining stringent quality standards. With the growing regulatory emphasis on RNA therapeutics, companies are investing in advanced template synthesis techniques, including error-free transcription systems and contamination-free enzymatic approaches, to ensure compliance with Good Manufacturing Practice (GMP) standards. Furthermore, the collaborations between academic research institutions, biotech firms, and contract development and manufacturing organizations (CDMOs) are accelerating IVT template innovation, enabling large-scale production and commercialization of RNA-based therapeutics.

As RNA-based medicine continues to revolutionize healthcare, the demand for highly efficient, scalable, and precisely engineered in-vitro transcription templates is expected to grow, shaping the future of synthetic biology, genetic medicine, and biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the In-Vitro Transcription Templates market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (DNA templates, RNA templates, Templates & transcription kits, Other product types); Disease (Lifestyle disease, Genetic disease, Other diseases); Treatment (Vaccine, Therapeutic); Research Stage (Exploratory, Clinical); End-Use (Pharma & Biotech Companies, Academic & Research institutes, Contract research organizations)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • Agilent Technologies Inc.
  • Aldevron
  • Bio-Rad Laboratories Inc.
  • Bio-Synthesis Inc.
  • Cayman Chemical
  • Creative Diagnostics
  • Danaher Corporation
  • Enzo Life Sciences Inc.
  • Enzynomics Co., Ltd.
  • Eurofins Genomics LLC
  • Genaxxon BioScience GmbH
  • GeneCopoeia
  • GenScript Biotech Corporation
  • Illumina Inc.
  • Integrated DNA Technologies Inc.
  • LGC Biosearch Technologies
  • Lucigen Corporation
  • Merck KGaA
  • New England Biolabs
  • Norgen Biotek Corporation
  • OriGene Technologies Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Synbio Technologies
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TriLink BioTechnologies
  • Vazyme Biotech Co., Ltd.
  • VectorBuilder Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • In-Vitro Transcription Templates - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rapid Expansion of mRNA Therapeutics and Vaccines Drives High-Volume Demand for IVT Templates
    • Growth in Cell and Gene Therapy R&D Strengthens Role of IVT Templates in Vector and RNA Synthesis
    • OEM Partnerships With CDMOs and Biotech Firms Spur Template Customization and Scale-Up Innovation
    • Rising Adoption of Self-Amplifying RNA and Circular RNA Boosts Need for Specialized Transcription Templates
    • Increased Investment in Personalized Cancer Vaccines Enhances Market for Custom IVT Template Production
    • Integration of IVT Templates Into Synthetic Biology Platforms Expands Application Beyond Therapeutics
    • Improved Plasmid Linearization and Template Purity Enhances Transcription Efficiency and Yield
    • Use of Enzyme-Modified and Cap-Integrated Templates Accelerates Translation Efficiency
    • Emerging Use of IVT in CRISPR Guide RNA Production Creates New Use Cases Across Research Fields
    • OEM Need for Templates With Regulatory-Grade Consistency Promotes GMP-Compliant Manufacturing
    • Increased Focus on Template Scalability Supports Transition From Bench to Clinic
    • IVT Template Supply Chain Resilience Becomes Critical Amid Global mRNA Development Booms
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World In-Vitro Transcription Templates Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for DNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for DNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for RNA templates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for RNA templates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Templates & transcription kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Templates & transcription kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other product types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other product types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Exploratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Exploratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Academic & Research institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Academic & Research institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Contract research organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Contract research organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Lifestyle disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Lifestyle disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Genetic disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Genetic disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Therapeutic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Therapeutic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • JAPAN
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 52: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • CHINA
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • EUROPE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 72: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for In-Vitro Transcription Templates by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • FRANCE
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 84: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • GERMANY
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 94: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • UNITED KINGDOM
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 114: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • ASIA-PACIFIC
    • In-Vitro Transcription Templates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Product Type - DNA templates, RNA templates, Templates & transcription kits and Other product types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Product Type - Percentage Breakdown of Value Sales for DNA templates, RNA templates, Templates & transcription kits and Other product types for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Research Stage - Exploratory and Clinical - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Research Stage - Percentage Breakdown of Value Sales for Exploratory and Clinical for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by End-Use - Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research institutes and Contract research organizations for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Disease - Lifestyle disease, Genetic disease and Other diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Disease - Percentage Breakdown of Value Sales for Lifestyle disease, Genetic disease and Other diseases for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for In-Vitro Transcription Templates by Treatment - Vaccine and Therapeutic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for In-Vitro Transcription Templates by Treatment - Percentage Breakdown of Value Sales for Vaccine and Therapeutic for the Years 2025 & 2030

IV. COMPETITION